Summary Information:
FSD Pharma Inc. Class B Subordinate Voting Shares
NASDAQ:HUGE


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


FSD Pharma Inc. Class B Subordinate Voting Shares
Exchange: NASDAQ
Symbol: HUGE
SEC CIK: 0001771885
Phone: (416) 854-8884
FIRST CANADIAN PLACE
100 KING STREET WEST, SUITE 4000
TORONTO A6 M5X 1A4
CEO: Raza Bokhari
Price when page updated: 1.16 Date: 2023-11-30
Company Website:
fsdpharma.com

_Description: Innovet Italia is an innovative animal health company, founded in Italy in 1996. Its main goal is to bring scientific innovation in niche fields of the veterinary market. The philosophy that drives Innovet's development is to follow where nature leads, studying and mimicking natural protective body responses rather than 'artificially' fighting the mechanisms of diseases. Based on such a strategic idea, Innovet's research team discovered and patented a family of bioactive lipid amides (i.e., aliamides, whose parent compound is palmitoylethanolamide, PEA) able to naturally restore the physiological balance of the hyper-reactive tissues. PEA, its micronized and ultramicronized forms and various other congeners, are the main components of Innovet's innovative products. Innovet's commercial effort is mainly focused on the small animal health field, in many market segments (i.e. dermatology, orthopedics, oral health, uro-nephrology, behavior, gastroenterology, ophthalmology and algology).

IPO YEAR:

Sector:

Industry:

ADRTSO:

MarketCap:
44664967.00
Beta:
1.518450778760556
52 Week High:
4.44
52 Week Low:
1
52 Week Change:
-0.3905325443786982
Short Interest:

Short Date:

Shares Outstanding:
40437361
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
27 Oct 2022
Float:
0
return on Equity:
22.90%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$369.386M
ttmEPS:
0
Revenue:
$5.031B
Gross Profit:

Cash:

Debt:

Institution Percent:
96.70%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
1.10%
Return on Assets:
12.80%
Return on Capital:

Profit Margin:
6.30%
Price to Sales:
0.59
Price To Book:
1.90
Short Ratio:
4.92
PE Ratio:
0
Employees:
9
1Y Guesstimate
1.190:1.0:1




__The following are links to various summary and news pages for
__FSD Pharma Inc. Class B Subordinate Voting Shares [ HUGE ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30